about
Transcription initiation sites and promoter structure of the human TRAIL-R3 geneStatistical model to analyze quantitative proteomics data obtained by 18O/16O labeling and linear ion trap mass spectrometry: application to the study of vascular endothelial growth factor-induced angiogenesis in endothelial cellsRetinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.Biodistribution and Efficacy of Human Adipose-Derived Mesenchymal Stem Cells Following Intranodal Administration in Experimental Colitis.The linker region joining the catalytic and the regulatory domains of CnA is essential for binding to NFAT.A robust method for quantitative high-throughput analysis of proteomes by 18O labeling.Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.Cyclooxygenase-2: a therapeutic target in angiogenesis.Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study.Nonlinear optical 3-dimensional method for quantifying atherosclerosis burden.Inhibitors of the calcineurin/NFAT pathway.IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritisThe RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators.Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses.Identification of an essential site for transcriptional activation within the human T-cell receptor delta enhancer.Regulator of calcineurin 1 mediates pathological vascular wall remodelingSpecific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression.COX-2 limits prostanoid production in activated HUVECs and is a source of PGH2 for transcellular metabolism to PGE2 by tumor cells.A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes.Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion.Systematic characterization of phosphorylation sites in NFATc2 by linear ion trap mass spectrometry.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site.C/EBPβ and Nuclear Factor of Activated T Cells Differentially Regulate Adamts-1 Induction by Stimuli Associated with Vascular Remodeling.The Chromatin Remodeling Complex Chd4/NuRD Controls Striated Muscle Identity and Metabolic Homeostasis.p38γ and δ promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation.A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative ProteomicsDithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage.Deficiency of MMP17/MT4-MMP proteolytic activity predisposes to aortic aneurysm in mice.A major role for RCAN1 in atherosclerosis progressionMAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin.c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway.Oxidative stress induces loss of pericyte coverage and vascular instability in PGC-1α-deficient mice.
P50
Q28213507-2C75BEAB-D2E8-498E-A483-1C54928376AEQ30487947-37270D17-598F-46CF-A840-A8B1F18EB1B8Q30619787-9476A79D-8C95-4F74-9362-051B264CAF53Q33774583-5023A069-B478-4EE4-9FCA-A101D38D61A1Q34388233-35F00A8E-867B-4252-8918-BD4820713DACQ34454936-64D6A2EC-E5F5-4FF1-B49A-B5F90289F962Q34768853-05A610A4-432C-486C-9911-861F2CEE6A44Q35077006-F2CA30AF-9F8F-48FD-949A-15702E7A57E2Q35088064-5915ACEB-E60C-4438-8E46-D4787792B3C5Q35171810-288C1BE4-68D5-4E8E-965F-B08829A86195Q35743601-BF2F85E6-36D2-44D6-B4E6-0DFAB2D7F128Q36512506-00A40D93-3B10-4E81-A414-03EE845028FCQ37158993-F927DEE2-9277-4EC2-BF71-4326F5E26AA1Q37262107-AEF10367-857D-4FAD-9B10-72E9003E4586Q38332566-AA9ED3F4-2E25-42D4-B346-40B5D6180C36Q38583217-C2D4BA46-3476-40A2-82AD-B116F9E62DC3Q39018487-9F653EA3-2F69-49B7-84FA-37890427B6EAQ39444857-51CB7065-3EC6-4700-B15D-58907007825DQ39855168-C2ACC420-5A69-41CE-A013-BAD2E3450B00Q39898193-B2AFD006-CB7D-40A0-93C8-4FA53AF89A7CQ40009971-F4F358B8-4505-4F18-ABC0-25AD0205F22BQ40023776-884983B9-E408-475B-8B47-72C25DF6C7D0Q40144966-EB9A37E4-2D51-403D-BC82-D357501F691DQ40305397-CC9628EE-337C-46E5-A939-CB31E42F89DAQ40615752-D1993F93-D28F-4CFC-8245-6BBEFBBFE8C6Q40689085-177B39D7-1EBD-4915-9E39-267D9905E174Q40760059-60B378B5-5CFE-4C87-86AD-2791785BE8C1Q41093817-11DC401B-3157-486F-9FF4-4E40974F6B49Q41098279-669BF845-AC48-4EF6-8C41-A395792D026CQ41199494-262E56F1-2533-424F-AC79-540E8F4EDE74Q41745400-3289CDD6-DC6C-4B31-B1DA-BB08612F5502Q41866270-E2AD45EF-D977-41C6-A509-147F2463FD50Q42120621-42829207-CF8C-46C7-80A3-8EFA28734F28Q42804849-64168129-F2F0-471E-85DA-20128599BDC4Q43847020-EB810F68-07FE-419B-8EF9-6119C9027A13Q44832032-80CFA411-F5A0-4797-8071-017A9F059330Q45295559-C8769C54-1F5C-4886-92AE-748246FCAAADQ46428265-B68A0221-DD38-4918-B612-725BFB44CE0DQ46549387-522A557A-F7B0-41F0-8315-66031986FCEFQ46583757-8CC836F0-BCD5-436C-8E49-E23E4C69353C
P50
description
researcher ORCID ID = 0000-0001-5779-9122
@en
wetenschapper
@nl
name
Juan Miguel Redondo
@ast
Juan Miguel Redondo
@en
Juan Miguel Redondo
@es
Juan Miguel Redondo
@nl
type
label
Juan Miguel Redondo
@ast
Juan Miguel Redondo
@en
Juan Miguel Redondo
@es
Juan Miguel Redondo
@nl
prefLabel
Juan Miguel Redondo
@ast
Juan Miguel Redondo
@en
Juan Miguel Redondo
@es
Juan Miguel Redondo
@nl
P106
P21
P31
P496
0000-0001-5779-9122